Interested in Participating in an NF1 Study?

Gel Study

 

Purpose of Study

The purpose of this study is to test the safety and effectiveness of 2 concentrations of NFX-179 gel compared with placebo gel in reducing the appearance of cutaneous neurofibromas (cNFs) in subjects with Neurofibromatosis Type 1 (NF1).

 

Participant Criteria

  • Ages 18+
  • Diagnosed with neurofibromatosis type 1
  • Have 10 clinically diagnosed cNFs
  • 2 cutaneous neurofibromas on face

For more information click here.

NFlection Study Flyer